ATP6AP2 and cancer: PRR is found to be overexpressed in various types of cancer, including breast cancer, glioma, pancreatic ductal adenocarcinoma, adrenocortical cancer, prostate cancer, gastric cancer, and colorectal cancer [81,88,89,90,91,92,93,94,95].